Spring 2017

Welcome to the inaugural edition of the Temple Lung Center newsletter.

This publication will review recent developments in thoracic medicine and surgery and will present important new information tailored to busy clinicians.

A national leader in research and lung transplants, Temple Lung Center is on the forefront of technological developments in thoracic medicine. Our tripartite mission focuses on research, education and patient care.

For our physicians, research is a driving force that ultimately paves the way for improved outcomes for their patients. We consistently have more than 50 clinical trials open for patient enrollment. Our physicians have been leaders in every lung valve and coil trial in the treatment of COPD.

The Temple Lung Center works with the Lewis Katz School of Medicine at Temple University to train future leaders in pulmonary care. Our residents and fellows gain experience in a range of clinical settings, and have access to innovative research and advanced technologies for serving patients.

Our physicians consistently evaluate all options for patients regardless of the acuity of their condition. We have the fifth highest lung transplant volume in the nation, and aim to provide as many candidates as possible with this life-saving treatment.

Our goal is to provide you with up-to-date information and research material that is of value to you and your practice. If you have suggestions for making this communication more relevant for you, please give us a call at 215-707-8113.

Gerard J. Criner, MD

more >

Hyperinflation and the Benefits of Lung Reduction

Hyperinflation is one of the most important factors contributing to breathlessness, impaired quality of life, reduced exercise tolerance, onset of respiratory failure and death in COPD. Lung hyperinflation also impairs cardiovascular function and is associated with emphysema and reduced 6-minute-walk distances. Several recent studies explore the benefits of lung reduction on improving... Continue Reading >

Case Study in Thoracic Medicine and Surgery

A 59-year-old male has been treated at the Temple Lung Center for emphysema for 10 years. He carries alpha-1 antitrypsin deficiency genes “s” and “z,” which predispose him to severe emphysema. He is also a former smoker with a history of smoking 1–2 packs of cigarettes per day for 45 years (he stopped smoking in 2011). Pulmonary function test findings in 2010 led to... Continue Reading >

Antero-axillary Approach for Lung Transplantation: 10-year Experience

The antero-axillary approach for lung transplantation has grown in popularity since I first published on its use in 2007, and has become the standard of care at some institutions. It was developed in order to provide a minimally invasive approach that would spare muscles, sternum, and internal mammary arteries and veins, while allowing easy access for cardiopulmonary bypass... Continue Reading >